Showing results (1151-1160 of 1,221) with videos related to
Sort By:
Pageof 123
Nature|November 11, 2021
Diverse alterations associated with resistance to KRAS(G12C) inhibitionYulei Zhao, Yonina R Murciano-Goroff, Jenny Y Xue, et al.The Journal of Clinical Investigation|September 5, 2019
Genetic hallmarks of recurrent/metastatic adenoid cystic carcinomaAllen S Ho, Angelica Ochoa, Gowtham Jayakumaran, et al.Nature Communications|January 4, 2020
Identification of recurrent FHL2-GLI2 oncogenic fusion in sclerosing stromal tumors of the ovarySarah H Kim, Arnaud Da Cruz Paula, Thais Basili, et al.Nature Communications|November 12, 2015
Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasmaLeticia De Mattos-Arruda, Regina Mayor, Charlotte K Y Ng, et al.Blood|September 10, 2024
Selective targeting of mutated calreticulin by the monoclonal antibody INCA033989 inhibits oncogenic function of MPNEdimara S Reis, Rebecca Buonpane, Hamza Celik, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2021
Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast CancerCarmine De Angelis, Xiaoyong Fu, Maria Letizia Cataldo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 22, 2023
Genomic Profiling Reveals Germline Predisposition and Homologous Recombination Deficiency in Pancreatic Acinar Cell CarcinomaDiana Mandelker, Antonio Marra, Binbin Zheng-Lin, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 21, 2019
Ultra-deep next-generation sequencing of plasma cell-free DNA in patients with advanced lung cancers: results from the Actionable Genome ConsortiumB T Li, F Janku, B Jung, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 13, 2014
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014R Salgado, C Denkert, S Demaria, et al.International Immunopharmacology|November 11, 2023
MTOR gene variants are associated with severe COVID-19 outcomes: A multicenter studyBruna Ramos Tosta, Ingrid Marins de Almeida, Laiane da Cruz Pena, et al.Pageof 123